Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value
$142.60M
Total Bought
$17.99M
Total Sold
$19.98M
Net Transaction
-$1.99M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
KYMERA THERAPEUTICS INC(KYMR)782,219881,337+99,11810,87322,43915.74%+11,566
ARVINAS INC(ARVN)489,153489,15309,60720,13414.12%+10,527
SILENCE THERAPEUTICS PLC(SLN)1,312,2331,043,284-268,94912,88618,12212.71%+5,236
REPARE THERAPEUTICS INC0633,271+633,27104,6233.24%+4,623
BLUEPRINT MEDICINES CORP379,090254,827-124,26319,03823,50516.48%+4,467
ARROWHEAD PHARMACEUTICALS IN(ARWR)908,474908,474024,41127,79919.50%+3,389
SUTRO BIOPHARMA INC(STRO)0420,649+420,64901,8051.27%+1,805
REGENXBIO INC(RGNX)847,424802,424-45,00013,94914,40410.10%+455
MERUS N V430,109355,109-75,00010,1429,7656.85%-376
PIERIS PHARMACEUTICALS INC3,303,1900-3,303,1909840—-984
OLEMA PHARMACEUTICALS INC(OLMA)88,8750-88,8751,0980—-1,098
ARGENX SE(ARGX)3,7150-3,7151,8260—-1,826
GENMAB A/S(GMAB)52,1480-52,1481,8390—-1,839
C4 THERAPEUTICS INC(CCCC)1,990,3340-1,990,3343,7020—-3,702
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q4 2023 | TickerTrail